Vascular Endothelial Growth Factor, thrombelastography and coagulation in the context of etiology, outcome and clinical course of patients after circulatory arrest

Recruiting

• Conditions: I46; Cardiac arrest

• Registration Number: DRKS00033234
• Lead Sponsor: BG-Klinikum Unfallkrankenhaus Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Return of spontaneous circulation or decision to initiate ECLS (extracorporeal life support)

Exclusion Criteria

- Age < 18 years
- pregnancy
- Patient, legal guardians or authorized representatives do not give informed consent or relatives indicate that the presumed patient wishes contradict a participation.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Outcome at hospital discharge, according to Cerebral Performance Category (CPC)

Secondary Outcome Measures

Name	Time	Method
- Outcome at 3 months according to CPC<br>- Prognosis of hypoxic-ischemic encephalopathy<br>- Analysis of laboratory parameter and clinical findings in regard to coagulation. <br>- Organ failures and severity of post cardiac arrest syndrome.